Literature DB >> 11049728

Substance P: an historical perspective.

S E Leeman1, S L Ferguson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11049728     DOI： 10.1054/npep.2000.0826

Source DB:  PubMed          Journal:  Neuropeptides        ISSN： 0143-4179            Impact factor:   3.286


× No keyword cloud information.
  9 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides.

Authors:  Hiral J Patel; Shakti H Ramkissoon; Prem S Patel; Pranela Rameshwar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-16       Impact factor: 11.205

Review 3.  Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells.

Authors:  Silvia Di Angelantonio; Rashid Giniatullin; Valeria Costa; Elena Sokolova; Andrea Nistri
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

4.  Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.

Authors:  Irene Tsilioni; Irwin J Russell; Julia M Stewart; Rae M Gleason; Theoharis C Theoharides
Journal:  J Pharmacol Exp Ther       Date:  2016-01-13       Impact factor: 4.030

5.  IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.

Authors:  Theoharis C Theoharides; Bodi Zhang; Duraisamy Kempuraj; Michael Tagen; Magdalini Vasiadi; Asimenia Angelidou; Konstantinos-Dionysios Alysandratos; Dimitris Kalogeromitros; Shahrzad Asadi; Nikolaos Stavrianeas; Erika Peterson; Susan Leeman; Pio Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

6.  A two-step strategy to enhance activity of low potency peptides.

Authors:  Jamie R Doyle; Benjamin N Harwood; Subrahmanian Tarakkad Krishnaji; Vijay M Krishnamurthy; Wei-En Lin; Jean-Philippe Fortin; Krishna Kumar; Alan S Kopin
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

Review 7.  The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury.

Authors:  Annabel J Sorby-Adams; Amanda M Marcoionni; Eden R Dempsey; Joshua A Woenig; Renée J Turner
Journal:  Int J Mol Sci       Date:  2017-08-17       Impact factor: 5.923

Review 8.  The Role of Substance P in Secondary Pathophysiology after Traumatic Brain Injury.

Authors:  Robert Vink; Levon Gabrielian; Emma Thornton
Journal:  Front Neurol       Date:  2017-06-28       Impact factor: 4.003

9.  The role of substance p in ischaemic brain injury.

Authors:  Renée J Turner; Robert Vink
Journal:  Brain Sci       Date:  2013-01-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.